The FDA has approved ProVate (ConTIPI) for the temporary, nonsurgical management of pelvic organ prolapse in women.
FDA Recalls Transvaginal Mesh for Treatment of Pelvic Organ Prolapse
Mayo Clinic offers comprehensive care for women with pelvic floor disorders such as pelvic organ prolapse and urinary incontinence - Mayo Clinic
Nonsurgical Treatment for Pelvic Organ Prolapse
Pelvic Organ Prolapse — THE PELVIC MEDICINE CENTRE
FDA Panel Takes Second Look at Treatment - WSJ
Pelvic Organ Prolapse Treatment - Evidence for Conservative Approach
Text - Pelvic Organ Prolapse: Nonsurgical Treatment
ConTIPI Medical Has Received FDA Approval for the Marketing of a Unique Product for the Treatment of Pelvic Organ Prolapse in Women
ELITONE: Pelvic Floor Therapy that is Non-intrusive and Easy
Non-Surgical Treatment of Uterus Prolapse by Uterus Prolapsed - Issuu
Verve Medical Announces FDA Approval of IDE for Pivotal Trial of RPD™ Renal Pelvic Denervation System for Treatment of Uncontrolled Hypertension